Hem › Icke-småcellig lungcancer › Kalifornien › Mountain View
Kliniska studier för Icke-småcellig lungcancer i Mountain View, CA
21 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Mountain View (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RekryterarFas 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi bort
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekryterarFas 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi bort
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi bort
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
RekryterarFas 3
- Stanford University, Stanford · 5 mi bort
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RekryterarFas 2
- Stanford Cancer Institute, Stanford · 5 mi bort
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekryterarObservationsstudie
- Stanford University, Palo Alto · 5 mi bort
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekryterarFas 2
- Stanford Cancer Institute, Stanford · 5 mi bort
- Stanford Hospital and Clinics, Stanford · 5 mi bort
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi bort
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekryterarFas 3
- Stanford Cancer Center, Palo Alto · 5 mi bort
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekryterarFas 1/2
- Stanford Cancer Institute, Stanford · 5 mi bort
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
RekryterarFas 1/2
- Stanford University Medical Center - Neurology, Stanford · 5 mi bort
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekryterarFas 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi bort
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
RekryterarFas 1/2
- Stanford Cancer Institute, Stanford · 5 mi bort
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
RekryterarFas 1/2
- Stanford University Medical Center, Stanford · 5 mi bort
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RekryterarFas 1
- Stanford University Medical Center, Palo Alto · 5 mi bort
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekryterarFas 1
- Stanford University, Palo Alto · 5 mi bort
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekryterarFas 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi bort
A Study of LY4175408 in Participants With Advanced Cancer
RekryterarFas 1
- Stanford Medicine Cancer Center, Stanford · 5 mi bort
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekryterarFas 1/2
- Stanford University, Stanford · 5 mi bort
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RekryterarFas 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi bort
Engagement of Veterans With Lung Cancer
Rekryterar
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi bort
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekryterarFas 1
- Stanford University, Stanford · 5 mi bort
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Mountain View
- Cancer (alla typer)40 studier
- Bröstcancer26 studier
- Metastaserande cancer25 studier
- Akut myeloid leukemi19 studier
- Äggstockscancer19 studier
- Autismspektrumstörning17 studier
- Lungcancer17 studier
- Prostatacancer15 studier
- Hjärtsvikt15 studier
- Autism13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal cancer13 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.